Parathyroid Tumor Clonal Status
Washington University School of Medicine · NCT05997810
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 839
- US sites recruiting
- 1
- Study start
- July 28, 2023
- Record last updated
- May 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).
Conditions: Parathyroid Tumor; Primary Hyperparathyroidism; Secondary Hyperparathyroidism (SHPT); Tertiary Hyperparathyroidism
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 1. Diagnosed with hyperparathyroidism (primary, secondary, or tertiary), biochemically confirmed (e.g., serum calcium and/or intact PTH consistent with the underlying etiology), and undergoing clinically indicated management
- Female and male patients
- Age ≥ 18 years
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
Exclusion Criteria
- Patients with a history of cervicofacial irradiation.
- Patients currently taking lithium or with a history of lithium use.
- Pregnant patients
Recruiting US locations
Washington University School of Medicine
St Louis, MO 63110
Site contact: Bryan Bear · 314-651-9717 · bearb@wustl.edu
Study contacts (from the official record)
- John A Olson, MD · (314) 362-8020 · jaolsol@wustl.edu
- Kathleen Harris · (314) 273-1433 · harrisk@wustl.edu
Similar studies in Missouri
All healthy volunteers studies in Missouri →- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 2 mo–1